Results 21 to 30 of about 422,254 (308)

Ethosomes: A novel drug carrier

open access: yesAnnals of Medicine & Surgery, 2022
Ethosomal systems are newer lipid vesicular carriers that have been around for 20 years, but over that period they have grown significantly as a means of transdermal drug delivery. They have a sizable amount of ethanol in them. These nanocarriers carry medicinal substances with various physicochemical qualities throughout the skin and deep skin layers.
Chauhan, Neha   +6 more
openaire   +2 more sources

Cyclodextrin-based nanosponges as drug carriers

open access: yesBeilstein Journal of Organic Chemistry, 2012
Cyclodextrin-based nanosponges, which are proposed as a new nanosized delivery system, are innovative cross-linked cyclodextrin polymers nanostructured within a three-dimensional network.
Francesco Trotta   +2 more
doaj   +1 more source

Vesicular Carriers for Follicular Drug Delivery [PDF]

open access: yesPharmaceutical Sciences
The follicular route has been explored for both topical and systemic drug delivery but its application is challenged by different limitations such as sebum flow and size-selectivity.
Mostafa Amirinejad   +3 more
doaj   +1 more source

Drug-related mutational patterns in hepatitis B virus (HBV) reverse transcriptase proteins from Iranian treatment-Naïve chronic HBV patients [PDF]

open access: yes, 2013
Background: Immunomodulators and Nucleotide analogues have been used globally for the dealing of chronic hepatitis B virus (HBV) infection. However, the development of drug resistance is a major limitation to their long-term effectiveness.
Abedi, F.   +33 more
core   +1 more source

Vapor nanobubble is the more reliable photothermal mechanism for inducing endosomal escape of siRNA without disturbing cell homeostasis [PDF]

open access: yes, 2020
Strategies for controlled delivery of therapeutic siRNA into living cells are in high demand as endosomal escape remains the most prominent bottleneck at the intracellular level.
Barriga, Gerardo Garcia-Diaz   +16 more
core   +3 more sources

Preparation of amphiphilic magnetic polyvinyl alcohol targeted drug carrier and drug delivery research

open access: yesDesigned Monomers and Polymers, 2020
Currently, magnetic applications have great potential for development in the field of drug carriers. In this paper, Fe3O4-PVA@SH, an amphiphilic magnetically targeting drug carrier, was prepared by using Fe3O4 and PVA with thiohydrazide ...
Yazhen Wang   +6 more
doaj   +1 more source

Efficient integration and fast excretion of drug carrier: The trojan horse for cancer therapy

open access: yesSmart Materials in Medicine, 2020
Macromolecular engineering has benefited the fabrication of drug delivery systems, owing to the versatile and tunable physical and chemical properties of the polymeric carriers as needed. However, the slow excretion rate of the macromolecule carriers has
Wang Zhen, Wenguo Cui
doaj   +1 more source

Effect of Cilostazol-Loaded PCL/PEG Nanocapsules on Abdominal Aortic Tunics and Lipid Profile of Wistar Rats [PDF]

open access: yesBrazilian Archives of Biology and Technology, 2020
Cilostazol (CLZ) is a phosphodiesterase III inhibitor with antiplatelet and vasodilator properties. It has been recently verified that CLZ plays a significant role in the arteries by inhibiting the proliferation and growth of muscle cells, increasing the
Luís Daniel Silva Pilatti   +6 more
doaj   +1 more source

A systematic approach to the formulation of anti-onychomycotic nail patches [PDF]

open access: yes, 2018
Nail patches have a potential role as drug carriers for the topical treatment of nail diseases such as onychomycosis, a common condition. O ur aim was therefore to develop a systematic and novel appr oach to the formulat ion of a simple drug -in-adhesive
Charalambides, MN   +5 more
core   +1 more source

Chitosan Contribution to Therapeutic and Vaccinal Approaches for the Control of Leishmaniasis

open access: yesMolecules, 2020
The control of leishmaniases, a complex parasitic disease caused by the protozoan parasite Leishmania, requires continuous innovation at the therapeutic and vaccination levels.
Philippe M. Loiseau   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy